[Accepted Manuscript] Effect of previous history of cancer on survival of patients with a second cancer of the head and neck.


Jégu, J.; Belot, A.; Borel, C.; Daubisse-Marliac, L.; Trétarre, B.; Ganry, O.; Guizard, A.V.; Bara, S.; Troussard, X.; Bouvier, V.; Woronoff, A.S.; Colonna, M.; Velten, M.; (2015) [Accepted Manuscript] Effect of previous history of cancer on survival of patients with a second cancer of the head and neck. Oral oncology. ISSN 1368-8375 DOI: https://doi.org/10.1016/j.oraloncology.2015.01.010 (In Press)

WarningThere is a more recent version of this item available.
[img] Text - Accepted Version
License:

Download (137kB)

Abstract

To provide head and neck squamous cell carcinoma (HNSCC) survival estimates with respect to patient previous history of cancer. Data from ten French population-based cancer registries were used to establish a cohort of all male patients presenting with a HNSCC diagnosed between 1989 and 2004. Vital status was updated until December 31, 2007. The 5-year overall and net survival estimates were assessed using the Kaplan-Meier and Pohar-Perme estimators, respectively. Multivariate Cox regression models were used to assess the effect of cancer history adjusted for age and year of HNSCC diagnosis. Among the cases of HNSCC, 5553 were localized in the oral cavity, 3646 in the oropharynx, 3793 in the hypopharynx and 4550 in the larynx. From 11.0% to 16.8% of patients presented with a previous history of cancer according to HNSCC. Overall and net survival were closely tied to the presence, or not, of a previous cancer. For example, for carcinoma of the oral cavity, the five-year overall survival was 14.0%, 5.9% and 36.7% in case of previous lung cancer, oesophagus cancer or no cancer history, respectively. Multivariate analyses showed that previous history of cancer was a prognosis factor independent of age and year of diagnosis (p<.001). Previous history of cancer is strongly associated with survival among HNSCC patients. Survival estimates based on patients' previous history of cancer will enable clinicians to assess more precisely the prognosis of their patients with respect to this major comorbid condition.

Item Type: Article
Faculty and Department: Faculty of Epidemiology and Population Health > Dept of Non-Communicable Disease Epidemiology
URI: http://researchonline.lshtm.ac.uk/id/eprint/2374062

Available Versions of this Item

Statistics


Download activity - last 12 months
Downloads since deposit
54Downloads
131Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item